AI in Life Sciences

About AI in Life Sciences

Healthcare innovation is moving fast, but are we leaving the patient behind? The Patient Signal is the essential briefing for patient advocates, policymakers, and health tech innovators who need to understand the human impact of new technology. We move beyond the hype of funding rounds and stock prices to focus on what matters most: access, outcomes, and equity. Each episode breaks down the critical intersection of Artificial Intelligence, Life Sciences, and Government Policy. We filter the noise to find the specific tools and regulations that are changing the patient journey right now. If you are building the future of care or fighting for those who need it, this is your signal. What we cover: Health Policy: New CMS rulings and legislative updates affecting access. AI Innovation: Practical tools for diagnostics and remote care. Advocacy: Victories and challenges from the patient community.

Publisher

Stan Berteloot

Category

news · science

Language

en

Explicit

No

First episode

22 Mar 2024

Latest episode

1 Apr 2026

Latest episodes

10 of 42 episodes have a transcript.

1. 

   1 Apr 2026TRANSCRIPT

   Heart Pump Trials Question Routine Use; Caris Detect Advances; Genomic Testing Tackles Disparities

   Host Stan Berteloot interviews industry experts on new heart pump trial results, Caris Life Sciences' cancer detection advancements, and genomic testing's role in addressing breast cancer disparities.

2. 

   31 Mar 2026TRANSCRIPT

   UCSB's MRI Breakthrough, Labcorp's Expansion, AI in Genomics, UK Drug Pathway, Ohio's Biomanufacturing Boost, Blackstone's Record Fund, IO Biotech Bankruptcy

   Journalist Stan Berteloot explores groundbreaking life science and healthcare advancements, including MRI breakthroughs, AI in genomics, and biotech funding shifts.

3. 

   13 Feb 2026TRANSCRIPT

   Unlocking Biotech's Future: AI, Atrandi's Innovations, and Generative AI in Drug Discovery

   AI expert Stan Berteloot explores how AI and Atrandi's innovations are revolutionizing drug discovery and enhancing biotech's future.

Inside a recent episode

Heart Pump Trials Question Routine Use; Caris Detect Advances; Genomic Testing Tackles Disparities

Published 1 Apr 2026 · Transcript excerpt

[…] The CHIP BCIS -3 trial revealed that the pump did not reduce major adverse events during complex percutaneous coronary interventions and was linked to a higher death rate among patients with severe left ventricular dysfunction. The STEMI -DTU trial found no improvement in outcomes for heart attack patients without cardiogenic shock. Both studies presented at the American College of Cardiology's annual meeting suggest a more selective approach to using mechanical circulatory support. Despite FDA approval for high -risk PCI, the trials indicate the need for further evidence before routine use. Johnson and Johnson remains committed to researching targeted therapies for these patients. […]

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

Apple Podcasts (US)

5.0 / 5

1 ratings

Contact AI in Life Sciences

Guest appearances

Books guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.

Questions about AI in Life Sciences